T. Tsujikawa, Y. Yoshida, T. Kudo, Y. Kiyono, T. Kurokawa et al., Functional Images Reflect Aggressiveness of Endometrial Carcinoma: Estrogen Receptor Expression Combined with 18F-FDG PET, Journal of Nuclear Medicine, vol.50, issue.10, pp.1598-1604, 2009.
DOI : 10.2967/jnumed.108.060145

T. Olafsen, V. Kenanova, G. Sundaresan, A. Anderson, D. Crow et al., Optimizing Radiolabeled Engineered Anti-p185HER2 Antibody Fragments for In vivo Imaging, Cancer Research, vol.65, issue.13, pp.5907-5916, 2005.
DOI : 10.1158/0008-5472.CAN-04-4472

J. Schuhmacher, S. Kaul, G. Klivényi, H. Junkermann, A. Magener et al., Immunoscintigraphy with positron emission tomography: gallium-68 chelate imaging of breast cancer pretargeted with bispecific anti-MUC1/anti-Ga chelate antibodies, Cancer Res, vol.61, pp.3712-3729, 2001.

E. Dijkers, J. Kosterink, A. Rademaker, L. Perk, G. Van-dongen et al., Development and Characterization of Clinical-Grade 89Zr-Trastuzumab for HER2/neu ImmunoPET Imaging, Journal of Nuclear Medicine, vol.50, issue.6, pp.974-981, 2009.
DOI : 10.2967/jnumed.108.060392

R. Baum, V. Prasad, D. Müller, C. Schuchardt, A. Orlova et al., Molecular Imaging of HER2-Expressing Malignant Tumors in Breast Cancer Patients Using Synthetic 111In- or 68Ga-Labeled Affibody Molecules, Journal of Nuclear Medicine, vol.51, issue.6, pp.892-897, 2010.
DOI : 10.2967/jnumed.109.073239

H. Kaplan and J. Malmgren, Impact of Triple Negative Phenotype on Breast Cancer Prognosis, The Breast Journal, vol.7, issue.5, pp.456-63, 2008.
DOI : 10.1111/j.1524-4741.2008.00622.x

S. Heskamp, H. Van-laarhoven, J. Molkenboer-kuenen, G. Franssen, Y. Versleijen-jonkers et al., ImmunoSPECT and ImmunoPET of IGF-1R Expression with the Radiolabeled Antibody R1507 in a Triple-Negative Breast Cancer Model, Journal of Nuclear Medicine, vol.51, issue.10, pp.1565-1572, 2010.
DOI : 10.2967/jnumed.110.075648

C. Rousseau, A. Ruellan, K. Bernardeau, F. Kraeber-bodéré, S. Gouard et al., Syndecan-1 antigen, a promising new target for triple-negative breast cancer immuno-PET and radioimmunotherapy. A preclinical study on MDA-MB-468 xenograft tumors, EJNMMI Research, vol.1, issue.1, p.20, 2011.
DOI : 10.1016/j.ejca.2004.01.038

URL : https://hal.archives-ouvertes.fr/inserm-00626326

J. Mortimer, J. Bading, D. Colcher, P. Conti, P. Frankel et al., Functional imaging of human epidermal growth factor receptor 2-positive metastatic breast cancer using (64)Cu-DOTA- trastuzumab PET, J Nucl Med, vol.55, issue.1, pp.201423-201432